LEXEO Therapeutics Funding: $185M Raised, Series B (2021)

LEXEO Therapeutics funding overview

LEXEO Therapeutics is based in New York City, New York. LEXEO Therapeutics has raised $185M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series B announced in September 2021. The round record for LEXEO Therapeutics runs through 2021; nothing later has been disclosed. Investors on record include D1 Capital Partners, Eventide Asset Management, CAM Capital, Verition Fund Management, Laurion Capital Management, Gray’s Creek Capital Partners and 8 others. 14 distinct backers are named across the disclosed rounds.

LEXEO Therapeutics at a glance

Total raised: $185M
Latest round: Series B
Latest round date: September 2021
Headquarters: New York City, New York
Notable investors: D1 Capital Partners, Eventide Asset Management, CAM Capital, Verition Fund Management, Laurion Capital Management, Gray’s Creek Capital Partners, Longitude Capital, Omega Funds

Frequently asked about LEXEO Therapeutics funding

How much has LEXEO Therapeutics raised?: LEXEO Therapeutics has raised $185M in total disclosed funding across the rounds on record.
Who has invested in LEXEO Therapeutics?: D1 Capital Partners, Eventide Asset Management, CAM Capital, Verition Fund Management, Laurion Capital Management, Gray’s Creek Capital Partners are named among the investors backing LEXEO Therapeutics.
What was the latest LEXEO Therapeutics funding round?: The most recent disclosed round is a Series B, announced in September 2021.
Where is LEXEO Therapeutics based?: LEXEO Therapeutics is based in New York City, New York.
When did LEXEO Therapeutics last raise?: The last disclosed LEXEO Therapeutics round closed in September 2021 at Series B.

Round data for LEXEO Therapeutics is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in New York City and backer lists below.

LEXEO Therapeutics Funding: $185M Raised, Series B (2021)

LEXEO Therapeutics funding overview

LEXEO Therapeutics at a glance

Frequently asked about LEXEO Therapeutics funding

Companies related to LEXEO Therapeutics (36)

Browse related funding lists (5)